HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.

Abstract
Accumulation of intracellular beta-catenin, as a result of inactivation of the adenomatous polyposis coli (APC) gene or by mutation of the beta-catenin gene (CTNNB1) itself, is involved in a wide range of human cancers. By means of fluorescent differential display using a murine fibroblast cell line (L-MT), which expresses an activated form of beta-catenin that accumulates in the cells, we found that expression of murine monocyte chemotactic protein-3 (mMCP-3) was suppressed by activated beta-catenin. Inversely, expression of MCP-3 in human colon cancer cells was induced by depletion of beta-catenin after adenovirus-mediated transfer of wild-type APC genes into the cells. A reporter-gene assay indicated that the accumulation of beta-catenin in the nucleus suppressed activity of the MCP-3 promoter through a putative T-cell factor/lymphocyte enhancer factor (Tcf/LEF)-binding site, ATCAAAG; but when the promoter sequence contained a two-base substitution in the binding site, it failed to suppress reporter-gene (luciferase) activity. An electrophoretic mobility-shift assay using the putative Tcf/LEF-binding sequence revealed interaction of the candidate sequence with the beta-catenin complex. Furthermore, induction of MCP-3 cDNA into HT-29 colon cancer cells increased expression of two markers of differentiation: alkaline phosphatase and carcinoembryonic antigen. Our results implied that activation of beta-catenin through the Tcf/LEF signaling pathway may participate in colonic carcinogenesis by inhibiting MCP-3-induced differentiation of colorectal epithelial cells.
AuthorsM Fujita, Y Furukawa, Y Nagasawa, M Ogawa, Y Nakamura
JournalCancer research (Cancer Res) Vol. 60 Issue 23 Pg. 6683-7 (Dec 01 2000) ISSN: 0008-5472 [Print] United States
PMID11118053 (Publication Type: Journal Article)
Chemical References
  • CCL7 protein, human
  • CTNNB1 protein, human
  • CTNNB1 protein, mouse
  • Ccl7 protein, mouse
  • Chemokine CCL7
  • Cytokines
  • Cytoskeletal Proteins
  • DNA-Binding Proteins
  • Lymphoid Enhancer-Binding Factor 1
  • Monocyte Chemoattractant Proteins
  • Trans-Activators
  • Transcription Factors
  • beta Catenin
Topics
  • Animals
  • Base Sequence
  • Binding Sites
  • COS Cells
  • Cell Differentiation (genetics)
  • Chemokine CCL7
  • Chlorocebus aethiops
  • Colon (cytology)
  • Colonic Neoplasms (genetics, metabolism, pathology)
  • Cytokines
  • Cytoskeletal Proteins (genetics, metabolism)
  • DNA-Binding Proteins (genetics, metabolism)
  • Down-Regulation
  • HT29 Cells
  • Humans
  • L Cells
  • Lymphoid Enhancer-Binding Factor 1
  • Mice
  • Monocyte Chemoattractant Proteins (biosynthesis, genetics)
  • Promoter Regions, Genetic
  • Trans-Activators
  • Transcription Factors (genetics, metabolism)
  • beta Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: